Research
Molecular
Improving insulin sensitivity is anticipated to lower plasma glucose concentration and decrease CVD risk in T2DM patients, independent of glucose control.
Enhancing insulin sensitivity can be a key strategy in T2DM management.
StrongSupportsmedium confidence
Improving insulin sensitivity is anticipated to both lower the plasma glucose concentration and decrease CVD risk in T2DM patients, independent of glucose control.
Why this rating
The claims are based on a review of established mechanisms and anticipated outcomes.
Source
Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Muhammad Abdul‐Ghani et al. · Current Vascular Pharmacology · 2017
reviewCited 77×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →